Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173

NCT02217839 is registered in ClinicalTrials.gov with Aspireo Pharmaceuticals Limited as lead sponsor.

NCT NCT02217839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02217839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multiple Ascending Dose Tolerability, Pharmacokinetic and Pharmacodynamic Study of DG3173
Lead sponsor
Aspireo Pharmaceuticals Limited
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2012
Completion date
Not reported
Enrollment
42 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy